title: A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma.
authors.affiliation: Division of Hematology/Oncology, Department of Medicine, University of Miami Miller School of Medicine, Florida, USA.
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Hosein
authors.forename: Michael D
authors.initials: MD
authors.lastname: Craig
authors.forename: Martin S
authors.initials: MS
authors.lastname: Tallman
authors.forename: Ralph V
authors.initials: RV
authors.lastname: Boccia
authors.forename: Brian L
authors.initials: BL
authors.lastname: Hamilton
authors.forename: Jonathan J
authors.initials: JJ
authors.lastname: Lewis
authors.forename: Izidore S
authors.initials: IS
authors.lastname: Lossos
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001152:Arsenicals / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005978:Glutathione / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001152:Arsenicals; C515055:darinaparsin; D005978:Glutathione